Oxathera

Oxatera is a drug that is used to treat metastatic colorectal and ovarian cancer. It belongs to the group of alkylating agents derived from platinum.

The manufacturer of the drug is Tyutor Laboratory S.A.S.I.F.I.A. in Argentina. The international name of the drug is Oxaliplatin; its synonyms, such as Eloxatin, are also known.

Oxatera is available as a lyophilisate for the preparation of a solution that can be administered intravenously.

The main active substance of the drug is oxaliplatin. The drug may be used in combination with other chemotherapy drugs such as fluoropyrimidines.

However, like any other drug, Oxatera has contraindications and side effects.

Hypersensitivity to platinum and pregnancy are contraindications to the use of Oxatera.

Side effects may include headache, dizziness, convulsions, drowsiness, general weakness, peripheral sensory neuropathy, perioral and gastrointestinal dysesthesia.

Overall, Oxatera is an effective drug for the treatment of ovarian cancer and metastatic colorectal cancer. However, before you start using it, you should consult your doctor and read the instructions for use.